Janssen et al. (23) have reported that several thrombotic risk factors, such as hyperhomocysteinemia, MTHFR gene mutation, antiphospholipid antibodies (APL), and lipoprotein (a) [Lp(a)], were demonstrated to be independent risk factors for RVO. Here, MTHFR is linked to hyperhomocysteinemia.